Do I need a DEA number in every state? — DEA registration in every state

Before you commit

1. Describe the controlled-substance activities and states to DEA and the relevant state authority.
2. Use the DEA Registration Q&A for the state-by-state statement.
3. Review the regulation’s practice-location rule and exceptions separately.
4. Confirm employer approval and any current telemedicine prescribing requirements before use.

Begin with the controlled-substance activity

Identify the states in which you intend to administer, dispense or prescribe controlled substances and describe how the clinical work is organized. A question about a DEA number should include your profession, professional authority and actual practice locations. Ask the relevant state board or controlled-substance authority what its own requirements are for those services. The federal registration discussion does not replace a state professional license or any separate state controlled-substance requirement. If the employer supplies a general registration statement, ask who can explain how it applies to your specific arrangement rather than treating all multistate work as identical.

Attribute the state and location rules correctly

The state-by-state statement on this page comes from the linked DEA Registration Q&A. Separately, 21 CFR 1301.12 addresses a separate registration for each principal place of business or professional practice at one general physical location where controlled substances are manufactured, distributed, imported, exported or dispensed, subject to the regulation's exceptions. Those are related registration questions, but the regulation should not be cited as if it is the source of the Q&A's state-by-state prescribing statement. Consult the actual guidance and regulation for exceptions and ask DEA about their application. A short answer cannot determine how every institutional, remote or location-specific arrangement is treated.

Connect registration to the employer’s clinical process

Ask the employer which prescribing duties you would hold and what evidence it requires before enabling that work. For telemedicine, current federal encounter requirements and state rules need their own review; a registration does not automatically authorize every remote prescription. Confirm who keeps the records current and how changes in work locations are reviewed. NPs and PAs should verify their role-specific prescribing authority with the appropriate board as well. Keep state licensure, state controlled-substance requirements, DEA registration and organization approval distinct in the file. When any item remains uncertain, obtain a current determination from the responsible authority before using the assignment's schedule as evidence that prescribing is permitted.

Applying this to your situation

Ask who reviews the registration plan when the employer changes a work location or prescribing responsibility. A file prepared for the original role may not answer the new arrangement. Keep the current state-board and DEA guidance attached to the question being resolved rather than applying a broad rule without its exceptions. If the organization uses an institutional process, ask the responsible authority how it applies to you instead of assuming the arrangement covers every clinician. The practical objective is a verified answer for the actual work, not merely a registration number recorded in an onboarding checklist.

Sources and scope

• DEA: Registration Q&A
• 21 CFR 1301.12: separate registration for each principal place of business or professional practice
• DEA: state controlled-substance license requirements

Figures are from the cited source as published; check it for the latest.

General information, not legal, tax or insurance advice.